Overview

[11C]-PBR28 Positron Emission Tomography Study to Evaluate the Effect of ABT 555 in Subjects With Relapsing Forms of Multiple Sclerosis

Status:
Terminated
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
This open-label positron emission tomography (PET) study is designed to determine the effect of ABT-555 on translocator protein expression level in participants with relapsing forms of multiple sclerosis.
Phase:
Phase 1
Details
Lead Sponsor:
AbbVie